|Bid||0.1800 x 0|
|Ask||0.1850 x 0|
|Day's Range||0.1850 - 0.1850|
|52 Week Range||0.1000 - 0.2600|
|Beta (5Y Monthly)||0.06|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 30, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX), a global leader in teledermatology, announces that two of its long-standing directors have announced their intention to retire from the Board. Gary Van Nest joined the Board in November 2001 and was Chairman from 2008 until 2018. David Breukelman joined the Board in November 2015.
MedX Health Corporation ("MedX" or the "Company") (TSX-V: MDX) and Empower Clinics Inc. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) ("Empower" or the "Company") are pleased to announce a Memorandum of Understanding between the companies to pilot MedX’s leading-edge DermSecure™ Screening Platform at two select Empower Clinics in Ontario with plans for a broader market roll-out pending the pilot’s completion.
MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX), a global leader in teledermatology, is pleased to announce the appointment of veteran healthcare industry executive Paul Karam as Sales and Marketing Director, Europe, Middle East & Africa ("EMEA"), effective immediately. Mr. Karam will be reporting to the Managing Director for the EMEA region and strengthening the MedX global footprint in general and EMEA presence in particular.